Delivery Order SPE2DB20D7059-SPE2DB26FGRE3
- Not listed
- The Defense Logistics Agency awarded a $1,960.14 delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections on September 24, 2025, with completion scheduled for September 25, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The order will be fulfilled from the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $11,268.06 to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was...
- The Defense Logistics Agency awarded a $4,080.45 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on September 19, 2025, with completion scheduled for September 22, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a $14,455.29 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This firm fixed-price contract, with an ultimate completion date of August 5, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $22,877.40 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999. The delivery location is...
- The Defense Logistics Agency awarded a delivery order valued at $21,128.38 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order valued at $1,525.20 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injections on September 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 16, 2025. The product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at approximately $7,988 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on October 20, 2025, with completion expected by October 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order...
- The Defense Logistics Agency awarded a $4,278.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injections. The contract, with an ultimate completion date of September 24, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This award was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injections on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB26FGRE3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,669.03 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen injections on October 30, 2025, with completion scheduled for October 31, 2025. This firm fixed-price contract, which was competitively awarded with no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's SPE2DX indefinite delivery contract enables it to supply an extensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for Zepbound, a diabetes medication, exemplifies AmerisourceBergen's role in fulfilling specialized pharmaceutical requirements for the federal healthcare system through flexible contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 10/30/25 |